#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic candida Hypophosphatasia Lymphoma Haemophilia A without inhibitors Alveolar proteinosis Primary myelofibrosis Myocarditis Bronchopulmonary dysplasia Crigler-Najjar syndrome Emphysema Pulmonary tuberculosis Adrenogenital syndrome Bronchiectasis Skin angiosarcoma Arrhythmogenic right ventricular dysplasia More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Trials in Disease Cholangitis sclerosing – Treatment Glycogen storage disease type V – Treatment Mast cell activation syndrome Biotinidase deficiency – Diagnostics Myxofibrosarcoma – Diagnostics Angiosarcoma non-metastatic – Life with Disease Medulloblastoma recurrent – Diagnostics Alexander disease – Life with Disease Castleman’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MOLNUPIRAVIR Idecabtagene Vicleucel Ceftriaxone Sodium Tasipimidine Entrectinib Cannabidiol Teropavimab Imgn151 Frexalimab Inebilizumab Soya-Bean Oil Refined Tas3351 Menotrophin Fenofibrate Sumatriptan Succinate Dimeticone Lna043 Elacestrant Dihydrochloride Aticaprant Dalbavancin More therapies…

    Learn about Your Condition

    Post procedural complication Ischaemic skin ulcer Ovarian cancer metastatic Lower limb fracture Postoperative wound infection Leber's congenital amaurosis Oesophagogastroscopy Multiple system atrophy Pemphigoid Type IIa hyperlipidaemia Type 1 diabetes mellitus Hydrocephalus Metabolic syndrome Merycism Oral lichen planus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Long-term Effects of Secukinumab in Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Austria Belgium Bulgaria Croatia Czechia Greece +8
  • Study on the Effects of PF-07275315 and PF-07264660 for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Germany Poland
  • Study on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Mometasone Furoate Ph. Eur.
    • Mometasone Furoate
    Poland
  • Study Comparing Methylprednisolone Aceponate Ointment and a Drug Combination for Patients with Mild to Moderate Atopic Dermatitis

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Methylprednisolone Aceponate
    Germany
  • Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

    Not recruiting

    2 1
    Investigated Drugs:
    • Barzolvolimab
    Croatia Germany Poland Spain
  • Study on Prednisone and Antihistamine for Treating Acute Urticaria in Adults at the Emergency Department

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urticaria
    Investigated Drugs:
    • Prednisone
    France
Previous Page
1 … 40 41 42 43 44 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!